Multiple Myeloma | Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management

Featuring perspectives from Dr Hans Lee and Dr Saad Zafar Usmani, including the following topics: Introduction (0:00) Biology/Immunology; Overview (3:05) Current Available Data (19:40) Clinical Investigator Survey (33:11) Combinations/Ongoing Trials (55:40) CME information and select publications